BEONE MEDICINES LTD-ADR (ONC) Stock Analyst Ratings

NASDAQ:ONC • US07725L1026

322.37 USD
-29.86 (-8.48%)
At close: Feb 26, 2026
322.37 USD
0 (0%)
After Hours: 2/26/2026, 6:50:44 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to ONC. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 365.13. This target is 13.26% above the current price.
  • ONC was analyzed by 15 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about ONC.
  • In the previous month the buy percentage consensus was at a similar level.
  • ONC was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.

Related screens

Find peers with buy consensus above 85%
ONC Historical Analyst RatingsONC Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Price Target & Forecast

Price Low Median Mean High 322.37355.88364.43365.13385.62 - 10.39% 13.05% 13.26% 19.62%

Related screens

Find peers 30% below price target
ONC Current Analyst RatingONC Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10
Up and Down Grades
Date Firm Action Rating
2026-02-04 Barclays Maintains Overweight -> Overweight
2025-11-24 Truist Securities Initiate Buy
2025-11-18 RBC Capital Maintains Outperform -> Outperform
2025-11-10 Citigroup Maintains Buy -> Buy
2025-11-07 Citizens Maintains Market Outperform -> Market Outperform
2025-11-07 RBC Capital Maintains Outperform -> Outperform
2025-10-20 Morgan Stanley Maintains Overweight -> Overweight
2025-10-08 JP Morgan Maintains Overweight -> Overweight
2025-09-18 Barclays Initiate Overweight
2025-08-07 Guggenheim Maintains Buy -> Buy
2025-08-07 RBC Capital Maintains Outperform -> Outperform
2025-07-17 JP Morgan Maintains Overweight -> Overweight
2025-07-16 RBC Capital Maintains Outperform -> Outperform
2025-06-27 RBC Capital Reiterate Outperform -> Outperform
2025-06-27 JP Morgan Maintains Overweight -> Overweight
2025-06-27 Morgan Stanley Maintains Overweight -> Overweight
2025-05-08 Guggenheim Maintains Buy -> Buy
2025-05-08 RBC Capital Maintains Outperform -> Outperform
2025-04-28 RBC Capital Reiterate Outperform -> Outperform
2025-04-24 TD Securities Reiterate Buy -> Buy
2025-04-21 JP Morgan Maintains Overweight -> Overweight
2025-04-16 Guggenheim Reiterate Buy -> Buy
2025-04-10 Guggenheim Reiterate Buy -> Buy
2025-04-07 RBC Capital Initiate Outperform
2025-02-28 Citizens Capital Markets Maintains Market Outperform -> Market Outperform
2025-02-28 Macquarie Maintains Outperform -> Outperform

BEONE MEDICINES LTD-ADR / ONC FAQ

What is the average price target for BEONE MEDICINES LTD-ADR (ONC) stock?

15 analysts have analysed ONC and the average price target is 365.13 USD. This implies a price increase of 13.26% is expected in the next year compared to the current price of 322.37.


What is the consensus rating for ONC stock?

The consensus rating for BEONE MEDICINES LTD-ADR (ONC) is 82.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.